Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Department of Diagnostic and Interventional Neuroradiology, Hospital Bremen-Mitte gGmbH, Bremen, Germany.
J Neurointerv Surg. 2023 Sep;15(e1):e136-e141. doi: 10.1136/jnis-2022-019239. Epub 2022 Aug 26.
In patients with mild strokes the risk-benefit ratio of endovascular treatment (EVT) for tandem lesions has yet to be evaluated outside of current guideline recommendations. This study investigates the frequency as well as procedural and safety outcomes in daily clinical practice.
Using data from the German Stroke Registry-Endovascular Treatment (GSR-ET) we analyzed patients with anterior circulation stroke due to tandem-lesions and mild deficits. These patients were defined as ≤5 on the National Institutes of Health Stroke Scale (NIHSS). Recanalization was assessed with the modified Thrombolysis in Cerebral Infarction Scale (mTICI). Early neurological and long-term functional outcomes were assessed with the NIHSS change and modified Rankin scale (mRS), respectively. Safety assessment included periprocedural complications and the rate of symptomatic intracerebral hemorrhage (sICH).
A total of 61 patients met the inclusion criteria and were treated endovascularly for tandem lesions. The median age was 68 (IQR:59-76) and 32.9% (20) were female. Patients were admitted to the hospital with a median NIHSS score of 4 (IQR:2-5) and a median Alberta Stroke Programme Early CT Score (ASPECTS) of 9 (IQR:8-10). Successful recanalization (mTICI 2b-3) was observed in 86.9% (53). NIHSS decreased non-significantly (p=0.382) from baseline to two points (IQR:1-9) at discharge. Excellent (mRS≤1) and favorable (mRS≤2) long-term functional outcome at 90-days was 55.8% (29) and 69.2% (36), respectively. Mortality rates at 90-days were 9.6% (5) and sICH occurred in 8.2% (5).
EVT for tandem lesions in patients with mild anterior circulation stroke appears to be feasible but may lead to increased rates of sICH. Further studies comparing endovascular with best medical treatment (BMT) especially investigating the risk of periprocedural hemorrhagic complications, are needed.
轻度卒中患者的血管内治疗(EVT)的风险效益比在现行指南建议之外尚未得到评估。本研究在日常临床实践中调查了串联病变患者的频率以及程序和安全性结果。
利用德国卒中登记处-血管内治疗(GSR-ET)的数据,我们分析了因串联病变和轻度神经功能缺损导致的前循环卒中患者。这些患者定义为 NIHSS 评分≤5。采用改良脑梗死溶栓分级(mTICI)评估再通情况。采用 NIHSS 变化和改良 Rankin 量表(mRS)评估早期神经功能和长期功能结局。安全性评估包括围手术期并发症和症状性颅内出血(sICH)发生率。
共有 61 例患者符合纳入标准,并接受了血管内治疗串联病变。患者的中位年龄为 68(IQR:59-76),32.9%(20 例)为女性。患者入院时的 NIHSS 中位数为 4(IQR:2-5),阿尔伯塔卒中计划早期 CT 评分(ASPECTS)中位数为 9(IQR:8-10)。86.9%(53 例)患者获得了成功再通(mTICI 2b-3)。NIHSS 在出院时从基线非显著降低(p=0.382)至 2 分(IQR:1-9)。90 天的良好(mRS≤1)和有利(mRS≤2)长期功能结局分别为 55.8%(29 例)和 69.2%(36 例)。90 天死亡率为 9.6%(5 例),sICH 发生率为 8.2%(5 例)。
对于轻度前循环卒中的串联病变患者,EVT 似乎是可行的,但可能导致 sICH 发生率增加。需要进一步比较血管内治疗与最佳药物治疗(BMT)的研究,特别是研究围手术期出血性并发症的风险。